Ovarian cancer lacks effective screening, making early detection difficult; symptoms are often non-specific and include bloating, early satiety, and abdominal pain. Diagnosis involves imaging, biopsy, ...
Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...
InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...
Aranscia will provide software solutions to facilitate the delivery of results from InterVenn's flagship glycoproteomic liquid biopsy test.
Doctors later apologized after realizing that she didn’t have ovarian cancer and said tumors had been discovered elsewhere in her body A woman is opening up about undergoing an unnecessary ...
Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes. Your diagnosis of an early-stage (Stage 1) gynecologic ...
Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback